CLPT ClearPoint Neuro
ClearPoint Neuro earnings company data as of 4:45 AM ET 10/24
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 28 Oct | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by CLPT's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $185K sold by 1 insider outside a trading plan
- $2.2M sold by 1 insider under 10b5-1 plans
-
Joseph Burnett CEOPlanned sale$388K 20,000 shares at $19.38 15% of stakeTraded Jun 29 Filed Jul 1
-
Joseph Burnett CEOPlanned sale$1.1M 61,843 shares at $17.79Traded Jun 17 Filed Jun 22
-
Matthew B. Klein DirectorSale$185K 16,000 shares at $11.59 25% of stakeTraded May 21 Filed May 26
-
Joseph Burnett CEOPlanned sale$303K 19,951 shares at $15.17 9.4% of stakeTraded Feb 25 Filed Feb 26
-
Joseph Burnett CEOPlanned sale$46K 2,943 shares at $15.57 1.4% of stakeTraded Jan 26 Filed Jan 27
-
Joseph Burnett CEOPlanned sale$322K 20,000 shares at $16.12 63% of stakeTraded Jan 9 Filed Jan 13
-
Joseph Burnett CEOPlanned sale$714K 26,463 shares at $26.98 11% of stakeTraded Oct 10, 2025 Filed Oct 14, 2025
Also filed in the last 12 months, not counted as buying or selling: 28 option exercises, 17 stock grants, 15 share withholdings for taxes, and 2 sales to cover taxes.
SEC filings
Recent issuer filings from EDGAR, 12 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.